Skip to content
PharmaManufacturingIQ

How lyophilisation addresses challenges for cutting-edge therapies

Dr. Uwe Hanenberg, PhD, head of product imple­mentation, Recipharm, will discuss how lyophilisation addresses challenges for cutting-edge therapies.

By PharmaManufacturing IQ Staff
How lyophilisation addresses challenges for cutting-edge therapies
Published: | 4 min read
Share to X Share to Bluesky Share to Facebook Share to LinkedIn Share by email

Dr. Uwe Hanenberg, PhD, head of product imple­mentation, Recipharm, will discuss how lyophilisation addresses challenges for cutting-edge therapies.

Recipharm

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information